CABA vs LH · $143.9M cap vs P/E 23, rev $7.27B
Cabaletta Bio Inc (CABA) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Cabaletta Bio Inc (CABA) is a biotechnology company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
CABA does not have a complete income-statement cache yet.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
CABA currently screens at market cap $143.9M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the CABA and LH stock pages for the full models.
Not investment advice.